Table 2 Clinical characteristics after propensity score matching
Events | n (%) or mean ± SD | p-value | |
|---|---|---|---|
GST (n = 54) | Manual (n = 54) | ||
Cancer type | |||
Squamous cell carcinoma | 1 (2.0%) | 1 (2.0%) | 1.000 |
Adenocarcinoma | 42 (82.4%) | 41 (80.4%) | |
Other | 8 (15.7%) | 9 (17.6%) | |
Tumor location | |||
Segment | 34 63.0%) | 24 (44.4%) | 0.082 |
Lobe | 20 (37.0%) | 30 (55.6%) | |
Access type | |||
Single port | 20 (37.0%) | 30 (55.6%) | 0.155 |
Double port | 17 (31.5%) | 12 (22.2%) | |
Triple port | 17 (31.5%) | 12 (22.2%) | |
Pulmonary fissures | |||
Incomplete | 16 (30.2%) | 14 (25.9%) | 0.783 |
Less incomplete | 37 (69.8%) | 40 (74.1%) | |
Pulmonary fuction | |||
High | 44 (81.5%) | 44 (81.5%) | 1.000 |
Moderate | 10 (18.5%) | 10 (18.5%) | |
Pleural adhesions | |||
None | 35 (64.8%) | 36 (66.7%) | 0.804 |
Mild | 15 (27.8%) | 16 (29.6%) | |
Moderate | 4 (7.4%) | 2 (3.7%) | |
Cancer stage | |||
TNM_T | |||
1 | 5 (14.7%) | 3 (7.5%) | 0.569 |
1a | 18 (52.9%) | 19 (47.5%) | |
1b | 8 (23.5%) | 6 (15.0%) | |
1c | 0 (0%) | 1 (2.5%) | |
2 | 1 (2.9%) | 3 (7.5%) | |
2a | 1 (2.9%) | 3 (7.5%) | |
2b | 1 (2.9%) | 2 (5.0%) | |
3 | 0 (0%) | 2 (5.0%) | |
is | 0 (0%) | 1 (2.5%) | |
TNM_N | |||
0 | 34 (100%) | 37 (92.5%) | 0.299 |
2 | 0 (0%) | 3 (7.5%) | |
TNM_M | |||
0 | 23 (67.6%) | 32 (80.0%) | 0.345 |
x | 11 (32.4%) | 8 (20.0%) | |
Cormobidities | |||
Emphysema | 2 (3.7%) | 1 (1.9%) | 1 |
Diabetes | 6 (11.1%) | 6 (11.1%) | 1 |
Hypertension | 10 (18.5%) | 12 (22.2%) | 0.811 |
Other | 15 (27.8%) | 10 (18.5%) | 0.361 |